Assessment of point-of-care measurement of international normalised ratio using the CoaguChek XS Plus system in the setting of acute ischaemic stroke

Internal Medicine Journal

Volumn 43, Issue 11, 2013, Pages 1205-1209

  Nusa, D ^a   Harvey, I ^a   Almansouri, A Y ^d   Wright, S ^a   Neeman, T ^b   Ahmad, O ^a,c   Hughes, A R ^a,c   Lueck, C J ^a,c  

^a CANBERRA HOSPITAL   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c The Australian National University   (Australia)

^d King Abdulaziz University   (Saudi Arabia)

Author keywords

CoaguChek; INR; Ischaemic stroke; Point of care testing; Thrombolysis

Indexed keywords

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BRAIN ISCHEMIA; CAPILLARY BLOOD; CLINICAL ARTICLE; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; MALE; POINT OF CARE TESTING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYRINGE;

COAGUCHEK; INR; ISCHAEMIC STROKE; POINT-OF-CARE TESTING; THROMBOLYSIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION TESTS; BRAIN ISCHEMIA; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; STROKE;

EID: 84887730989     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12255     Document Type: Article

References (16)

1. Jauch EC, Saver JL, Adams HP, Jr, Bruno A, Connors JJ, Demaerschalk BM etal. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
2. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC etal. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703.
3. The IST-3 Collaborative Group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G etal. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352-2363.
4. Green TL, Mansoor A, Newcommon N, Stephenson C, Stewart E, Hill MD. Reliability of point-of-care testing of INR in acute stroke. Can J Neurol Sci 2008; 35: 348-351.
5. Rizos T, Herweh C, Jenetzky E, Lichy C, Ringleb PA, Hacke W etal. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants. Stroke 2009; 40: 3547-3551.
6. Walter S, Kostopoulos P, Haass A, Lesmeister M, Grasu M, Grunwald I etal. Point-of-care laboratory halves door-to-therapy-decision time in acute stroke. Ann Neurol 2011; 69: 581-586.
7. Jonsson M, Hillarp A, Svensson P. Comparison between Coaguchek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy. Thromb Res 2004; 114: 83-89.
8. Kong MC, Lim TG, Ng HJ, Chan YH, Lee LH. Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic. Ann Hematol 2008; 87: 905-910.
9. Jackson SL, Bereznicki LR, Peterson GM, Marsden KA, Jupe DM, Vial JH etal. Accuracy and clinical usefulness of the near-patient testing Coaguchek S international normalised ratio monitor in rural medical practice. Aust J Rural Health 2004; 12: 137-142.
10. Williams VK, Griffiths AB. Acceptability of Coaguchek S and Coaguchek XS generated international normalised ratios against a laboratory standard in a paediatric setting. Pathology 2007; 39: 575-579.
11. Greenway A, Ignjatovic V, Summerhayes R, Newall F, Burgess J, DeRosa L etal. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the Coaguchek XS System with venous INR and venous INR using an international reference thromboplastin preparation (rtf/95). Thromb Haemost 2009; 102: 159-165.
12. van den Besselaar AM, Pequeriaux NC, Ebben M, van der Feest J, de Jong K, Ganzeboom MB etal. Point-of-care monitoring of vitamin K-antagonists: validation of Coaguchek XS test strips with international standard thromboplastin. J Clin Pathol 2012; 65: 1031-1035.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
14. Miedema I, Luijckx GJ, De Keyser J, Koch M, Uyttenboogaart M. Thrombolytic therapy for ischaemic stroke in patients using warfarin: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2012; 83: 537-540.
15. Ruecker M, Matosevic B, Willeit P, Kirchmayr M, Zangerle A, Knoflach M etal. Subtherapeutic warfarin therapy entails an increased bleeding risk after stroke thrombolysis. Neurology 2012; 79: 31-38.
16. Drescher MJ, Spence A, Rockwell D, Staff I, Smally AJ. Point-of-care testing for coagulation studies in a stroke protocol: a time-saving innovation. Am J Emerg Med 2011; 29: 82-85.